Mapping the Antibody Repertoires in Ferrets with Repeated Influenza A/H3 Infections: Is Original Antigenic Sin Really “Sinful”?
preprint
OA: closed
Abstract
The influenza-specific antibody repertoire is continuously reshaped by infection and vaccination. The host immune response to contemporary viruses can be redirected to preferentially boost antibodies specific for viruses encountered early in life, a phenomenon called original antigenic sin (OAS) that is suggested to be responsible for diminished vaccine effectiveness after repeated vaccination. In this study, we used a new computational tool called Neutralization Map to determine the hemagglutination inhibition profiles of individual antibodies within ferret antisera elicited by repeated influenza A/H3 infections. Our results suggest that repeated infections continuously reshape the ferret antibody repertoire, but that a broadly neutralizing antibody signature can nevertheless be induced irrespective of OAS. Overall, our study offers a new way to visualize how immune history shapes individual antibodies within a repertoire, which may help inform future vaccine design.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (39)
- A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies via crossref
- Using Neutralization Landscapes to enumerate Antibody Behavior and Decompose Antibody Mixtures via crossref
- doi:10.1038/srep15279 via crossref
- doi:10.1093/cid/cis574 via crossref
- doi:10.1093/cid/ciy327 via crossref
- doi:10.1093/cid/ciy330 via crossref
- doi:10.1016/j.it.2017.08.003 via crossref
- doi:10.1093/infdis/jix173 via crossref
- doi:10.1093/infdis/jiy376 via crossref
- doi:10.1128/jvi.02871-14 via crossref
- doi:10.1126/scitranslmed.aad0522 via crossref
- doi:10.1084/jem.20130212 via crossref
- doi:10.1093/cid/cix269 via crossref
- doi:10.1371/journal.pone.0016650 via crossref
- doi:10.1093/cid/cir693 via crossref
- doi:10.1073/pnas.1409171111 via crossref
- doi:10.1128/cvi.05053-11 via crossref
- doi:10.1371/journal.pone.0002975 via crossref
- doi:10.1093/cid/ciu680 via crossref
- doi:10.1093/infdis/jiu650 via crossref
- doi:10.1093/cid/cit736 via crossref
- doi:10.1016/j.vaccine.2016.11.024 via crossref
- doi:10.1016/j.vaccine.2017.06.088 via crossref
- doi:10.1093/infdis/jix074 via crossref
- doi:10.3390/vaccines6020028 via crossref
- doi:10.1101/cshperspect.a038786 via crossref
- doi:10.4049/jimmunol.1801149 via crossref
- doi:10.1128/cvi.00396-10 via crossref
- doi:10.1371/journal.pbio.1002082 via crossref
- doi:10.1371/journal.pone.0009268 via crossref
- doi:10.1128/jvi.01581-17 via crossref
- doi:10.1016/j.ygeno.2012.06.003 via crossref
- doi:10.1093/infdis/jix526 via crossref
- doi:10.1073/pnas.96.24.14001 via crossref
- doi:10.1126/science.1256427 via crossref
- doi:10.1073/pnas.1920321117 via crossref
- doi:10.1086/595861 via crossref
- doi:10.1128/mbio.02281-16 via crossref
- doi:10.1371/journal.pone.0092153 via crossref
Source provenance
- crossref
- last seen: 2026-05-24T01:00:20.344428+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-12T06:46:07.823367+00:00